-
effectivehealthcare-admin.ahrq.gov/health-topics/high-blood-pressure
March 04, 2022 - Systematic Review Archived June 21, 2018
Sodium and Potassium Intake: Effects on Chronic Disease … Research Protocol March 1, 2017
Effects of Dietary Sodium and Potassium Intake on Chronic Disease … Treating Hypertension
Systematic Review Archived January 31, 2012
Chronic Kidney Disease … Outcomes In End-Stage Renal Disease
Research Report Archived July 30, 2010
Prompt … Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-medicine-1/research
January 01, 2020 - rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology. … Introduction
The treatment of rheumatoid arthritis (RA) with disease modifying anti-rheumatic drugs … (DMARDs) provides control of disease activity, slows joint erosions and improves quality of life. … remission after 3 years. 9 , 10 The lack of information on disease duration or disease activity measurements … The changing use of disease-modifying anti-rheumatic drugs in individuals with rheumatoid arthritis from
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1406.pdf
June 01, 2014 - None
of these approaches halts disease progression. … exacerbations, which may slow disease progression. … Chronic obstructive pulmonary disease (COPD) fact
sheet. [internet]. … /lung-disease/copd/resources/facts-figures/COPD-Fact-Sheet.html
http://www.lung.org/lung-disease/copd … Chronic obstructive pulmonary disease (COPD) fact sheet. [internet].
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Diabetes Rate
in Enrolled
Population
Total All 2006 32.8 8.7 26.4%
Age
Disabled/end stage
renal disease … Alaska Native
2006 0.1 0.1 36.0%
Total All 2007 32.3 8.8 27.3%
Age Disabled/end stage
renal disease … Alaska Native
2007 0.2 0.1 37.3%
Total All 2008 31.9 8.9 27.9%
Age Disabled/end stage
renal disease … Alaska Native
2006 9.7% 28.4% 6.4%
Total All 2007 8.1% 18.9% 5.0%
Age Disabled/end stage
renal disease … Without Diabetes and
Without PAD
Total All 2006 3.3% 11.0% 2.5%
Age Disabled/end stage
renal disease
-
effectivehealthcare-admin.ahrq.gov/products/ems-911-workforce-infection-control/protocol
December 01, 2022 - , benefits and harms) in studies of EMS/911 workforce practices to recognize and control infectious disease … government agencies or nongovernmental organizations that have an interest in this topic (e.g., Centers for Disease … including 911 dispatchers exposed to or at risk of exposure to an occupationally-acquired infectious disease … will use DistillerSR to extract information about the epidemiologic characteristics of the infectious disease … Multidrug-Resistant Organisms
Systematic Review
Nov 14, 2023
Cervical Degenerative Disease
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/crohns-disease_disposition-comments.pdf
February 25, 2014 - Studies that compared
Crohn’s disease patients to
patients without inflammatory
bowel disease were … instrument for adult
patients with inflammatory bowel
disease. … Public: UCB Results, KQ2 Crohn’s disease is a chronic inflammatory bowel disease with a relapsing and … Smith, MD
Abbreviations CDAI = Crohn’s disease activity index IBD = inflammatory bowel disease Thank … The incidence/prevalence is much smaller than other
chronic diseases such as rheumatoid arthritis.
-
effectivehealthcare-admin.ahrq.gov/products/future-research-needs-projects/overview
January 01, 2021 - Angiotensin II Receptor Blockers Added to Standard Medical Therapy for Treating Stable Ischemic Heart Disease … No. 26: Pharmacological Management of Crohn's Disease: Future Research Needs . … No. 33: Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease … No. 41: Noninvasive Technologies for the Diagnosis of Coronary Artery Disease in Women: Future Research … No. 42: Treatment Strategies for Women With Coronary Artery Disease: Future Research Needs .
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-222-health-equity-preventive-services-comments.pdf
December 03, 2019 - Correct, the scope of the review is limited to 10
preventive services for cancer, cardiovascular disease … backgrounds are receiving evidence-
based preventive services for individuals with
cardiovascular diseases … Julia Charles:
Centers for
Disease Control
and Prevention
In particular, subject matter experts … members of these populations to quit smoking and thereby
reduce their risk of developing smoking-related diseases … Julia Charles:
Centers for
Disease Control
and Prevention
Including studies and related analyses
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
April 01, 2015 - Analytic framework for discontinuing disease-modifying treatments for MS
DMT = disease-modifying treatment … and disease activity
after interrupting treatment. … stages of the disease, when
the side effects are less than disease symptoms. … course to prevent or delay
disease progression. … We cannot
currently predict early or benign disease courses.
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-hospitalizations/research
January 01, 2020 - selected common (pneumonia and congestive heart failure) and less frequent (sepsis, invasive pneumococcal diseases … serious renal (patients on hemodialysis), liver (hepatic coma and hepatorenal syndrome), or respiratory diseases … definitions for community-acquired pneumonia, sepsis, congestive heart failure, invasive pneumococcal diseases … Assessing the ability of our definitions to identify rare conditions, such as invasive pneumococcal diseases … This PPV depends on disease prevalence and the specificity of the definitions, 7 and when disease prevalence
-
effectivehealthcare-admin.ahrq.gov/health-topics/immune-system-and-disorders?page=0
March 23, 2018 - Allergy and asthma - immune responses to substances that are usually not harmful
Immune deficiency diseases … - disorders in which the immune system is missing one or more of its parts
Autoimmune diseases - … diseases causing your immune system to attack your own body's cells and tissues by mistake
NIH: National … Institute of Allergy and Infectious Diseases
Source
https://medlineplus.gov/immunesystemanddisorders.html … Asthma Management
Clinician Summary Archived July 26, 2016
Diagnosis of Celiac Disease
-
effectivehealthcare-admin.ahrq.gov/health-topics/immune-system-and-disorders
March 23, 2018 - Allergy and asthma - immune responses to substances that are usually not harmful
Immune deficiency diseases … - disorders in which the immune system is missing one or more of its parts
Autoimmune diseases - … diseases causing your immune system to attack your own body's cells and tissues by mistake
NIH: National … Institute of Allergy and Infectious Diseases
Source
https://medlineplus.gov/immunesystemanddisorders.html … Asthma Management
Clinician Summary Archived July 26, 2016
Diagnosis of Celiac Disease
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Beneficiaries, 2006-2008, by Age, Gender, and Race, and Broken Down by Diagnosis of
Peripheral Artery Disease … Alaska
Native
2006 6.9% 17.9% 5.0%
Total All 2007 6.0% 13.2% 4.0%
Age Disabled/end stage
renal disease … Alaska
Native
2007 6.8% 17.5% 4.9%
Total All 2008 6.0% 13.1% 3.9%
Age Disabled/end stage
renal disease … With Diabetes and
Without PAD
Total All 2006 0.5% 2.1% 0.053%
Age Disabled/end stage
renal disease … 2.08% 2.07% 1.93% 1.55%
Total All 2008 1.70% 1.78% 1.70% 1.43%
Age† Disabled/end stage renal
disease
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/copd-management_research.pdf
December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease
patients using theophylline. … disease (PUD), gastroesophogeal reflux disease (GERD),
arrhythmias, depression, hypertension, ischemic … A 4-year
trial of tiotropium in chronic obstructive
pulmonary disease. … The use of theophylline in
chronic obstructive pulmonary disease. … Chronic obstructive
pulmonary disease: a novel risk factor for
cardiovascular disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/decide16final-mortality-risk-in-copd-pts-using-theophylline.pdf
December 01, 2009 - Mortality risk in chronic obstructive pulmonary disease
patients using theophylline. … disease (PUD), gastroesophogeal reflux disease (GERD),
arrhythmias, depression, hypertension, ischemic … A 4-year
trial of tiotropium in chronic obstructive
pulmonary disease. … The use of theophylline in
chronic obstructive pulmonary disease. … Chronic obstructive
pulmonary disease: a novel risk factor for
cardiovascular disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/plasma-cell-dyscrasias-sflc-assay_executive.pdf
August 01, 2012 - monitoring.8,11 The SFLC
assay may also be the only means of detecting a disease
marker in some disease … disease settings, and their results need
to be evaluated with this in mind. … as well as different disease
populations. … Finally, variation in disease severity studied
can lead to spectrum bias. … of disease
(e.g., response to treatment, relapse, or light chain escape).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/dcis-mri-utilization_research.pdf
August 01, 2012 - increased
dramatically from 2002 to 2007 for both
women with DCIS (<1% to 12.9%) and with
invasive disease … Specifically, we
included International Classification of
Diseases for Oncology, Third Edition
(ICD-O … Among women with
invasive cancer, rates of MRI use de-
creased with higher grade disease. … The increase
was observed for both women with DCIS
and early invasive disease. … ) received more MRIs
prior to surgery than those with lower risk
disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0277_03-10-2008.pdf
January 01, 2008 - HSCTs are used to treat both malignant and non-malignant diseases in children. … HSCT is
associated with high morbidity and mortality in all ages and all diseases. … Factors that impact the
appropriateness and success of any HSCT include the stage and/or severity of the disease … ),
there is a large body of literature regarding HSCT across many diseases. … The diseases covered in the AHRQ review will be defined during the refinement
phase.
-
effectivehealthcare-admin.ahrq.gov/products/evidence-map/tech-brief
April 01, 2025 - impairment, high risk/frail conditions, and people with specific conditions, most commonly Parkinson disease … , Alzheimer disease, or end-stage kidney disease. … impairment, high-risk/frail conditions, and people with specific conditions, most commonly Parkinson’s disease … , Alzheimer’s disease, or end-stage kidney disease.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
December 01, 2023 - The Office of Disease
Prevention anticipated that the risk of postpartum maternal morbidity and mortality … stemmed from the fact that a number of states have added violence-
related questions to the Center for Disease … percent by comorbidities
(including prepregnancy body mass index, diabetes, hypertension, cardiac disease … , renal
disease, pulmonary disease, musculoskeletal disease, blood disorders, mental disorders, … 4
central nervous system disorders, rheumatic heart disease, anemia, and asthma).6 Finally,
if rural